Clinician FAQ
Kit orders can be placed online through our web portal. You can also place an order by calling us at +1 (855) 373-7978 or emailing us at [email protected].
Each kit will have a prepaid return label for shipping back to Personalis. Kits can be shipped at room temperature. For assistance with FedEx pick-up, contact [email protected].
NeXT DX reports can be delivered via secure email, fax and our Personalis Web Portal. If you have any questions, feel free to reach out to our Client Services team at [email protected] or by phone at +1 (855) 373-7978. We are available Monday to Friday from 9:00 am to 5:00 pm (PST).
Please contact our Client Services department at [email protected] or by phone at +1 (855) 373-7978. We are available Monday to Friday from 9:00 am to 5:00 pm (PST).
Turn around time for results is typically two weeks from sample receipt (both tumor and normal tissues).
For issues related to log in or password changes, please contact our Client Services department at [email protected] or by phone at +1 (855) 373-7978. We are available Monday to Friday from 9:00 am to 5:00 pm (PST).
To sign-up for a Personalis Clinical Portal account to place orders and access patient results online, please contact your local Personalis representative or our Client Services department at [email protected] or by phone at +1 (855) 373-7978. The Client Services department is available Monday to Friday from 9:00 am to 5:00 pm (PST).
Please complete the information on the test requisition form. If you would like to order through our web portal, contact [email protected] for assistance.
The NeXT Dx test can be ordered online through our portal or by filling out a Test Requisition Form. For questions about ordering the NeXT Dx test, please contact Personalis at [email protected], or give us a call at +1 (855) 373-7978. We are available Monday to Friday from 9:00 am to 5:00 pm (PST).
The NeXT Dx test is run at the Personalis Clinical Laboratory which is a CAP Accredited and CLIA Certified lab. View our certification documents here.
Blood can be collected at a physician’s office or we can facilitate at-home collection for blood or saliva.
We offer assistance with tissue acquisition.
The NeXT Dx test is validated for solid tumor FFPE samples. We accept biopsies, core needle biopsies, fine needle aspiration (FNA), and resection samples as tumor tissue. A detailed tumor tissue specimen preparation guide is listed here.
Blood or saliva samples are acceptable as matched normal samples.
We currently cannot accept samples coming from New York state for the NeXT Dx test.
A list of genes reported is located here.
Any patient with a solid tumor, including sarcoma, is eligible for NeXT Dx testing.
The NeXT Dx test helps identify potential therapies (targeted and/or immuno-therapies) and clinical trial options for patients with solid tumors.
The NeXT Dx test is a comprehensive genomics tumor profiling test based on whole exome and transcriptome sequencing. It is intended for profiling a solid tumor’s genomic and molecular characteristics using clinical-grade, next-generation sequencing (NGS) technology to report small nucleotide variants (SNVs), small insertions and deletions (indels), copy number alterations (CNAs), fusions, MSI and exome-wide “true” tumor mutational burden (TMB). Germline mutations are also reported as incidental findings from sequencing of the matched normal sample. In addition, mutations in genes involved in homologous recombination repair (HRR) are highlighted when identified.
Billing
For billing questions, patients may email [email protected] or call Patient Billing Services at +1 (855) 373-7974. We are available Monday to Friday from 6:30 am to 4:00 pm (PST).
Patients can make a payment using one of the following methods:
• We accept personal checks, money orders, and all major credit cards.
• Your patient may make payments online by visiting Bill Pay.
• Patients can also submit credit card payments over the phone by calling +1 (855) 373-7974.
• Patients may mail a personal check or money order to Personalis at 1330 O’Brien Dr. Menlo Park, CA 94025.
Yes, patients may contact Patient Billing Services at +1 (855) 373-7974 to learn more about our payment plans.
Yes, our NeXT Access financial assistance program is available to qualifying patients. To determine if patients qualify for NeXT Access, patients may contact Patient Billing Services at +1 (855) 373-7974. They can also complete our Financial Assistance Application and send it to us via:
Email: [email protected]
Fax: +1 (650) 469-0622
Mail: Personalis at 1330 O’Brien Dr. Menlo Park, CA 94025.
No, patients will not receive surprise medical bills nor be balance-billed. Patients will only be financially responsible for the amount that their health insurance company may apply as a copay, co-insurance, or deductible. We will apply their in-network benefits to their out-of-pocket costs.
We accept all health insurance plans. If we are out-of-network with your patient’s health insurance company, we will apply their in-network benefits to their out-of-pocket costs. We also accept self-pay.
The NeXT Dx test utilizes DNA isolated from a patient’s tumor tissue and matched normal tissue to perform whole exome analysis and RNA isolated from a patient’s tumor tissue to perform transcriptome analysis. The clinical report includes SNVs, indels, CNAs, MSI and TMB results derived from DNA analysis and fusion results derived from RNA analysis.
Contact Information
Client Services
+1 (855) 373-7978 or [email protected]
9:00 a.m. – 5:00 p.m. PST, weekdays.
Patient Billing Services
+1 (855) 373-7974 or [email protected]
6:30 a.m. – 4:00 p.m. PST, weekdays.
